London
· Delayed Price · Currency is GBP · Price in GBXCreo Medical Group Statistics
Total Valuation
Creo Medical Group has a market cap or net worth of GBP 101.14 million. The enterprise value is 90.94 million.
| Market Cap | 101.14M |
| Enterprise Value | 90.94M |
Important Dates
The last earnings date was Monday, September 9, 2024.
| Earnings Date | Sep 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Creo Medical Group has 351.78 million shares outstanding. The number of shares has increased by 72.61% in one year.
| Shares Outstanding | 351.78M |
| Shares Change (YoY) | +72.61% |
| Shares Change (QoQ) | +34.91% |
| Owned by Insiders (%) | 4.64% |
| Owned by Institutions (%) | 74.19% |
| Float | 315.22M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.92 |
| PB Ratio | 1.69 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.19 |
| EV / Sales | 2.95 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -3.99 |
Financial Position
The company has a current ratio of 3.83, with a Debt / Equity ratio of 13.88.
| Current Ratio | 3.83 |
| Quick Ratio | 2.94 |
| Debt / Equity | 13.88 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.36 |
| Interest Coverage | -62.00 |
Financial Efficiency
Return on equity (ROE) is -39.78% and return on invested capital (ROIC) is -24.01%.
| Return on Equity (ROE) | -39.78% |
| Return on Assets (ROA) | -20.42% |
| Return on Capital (ROIC) | -24.01% |
| Revenue Per Employee | 107,317 |
| Profits Per Employee | -75,610 |
| Employee Count | 287 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 1.78 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.54% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -11.54% |
| 50-Day Moving Average | 30.34 |
| 200-Day Moving Average | 34.91 |
| Relative Strength Index (RSI) | 41.76 |
| Average Volume (20 Days) | 391,021 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Creo Medical Group had revenue of GBP 30.80 million and -21.70 million in losses. Loss per share was -0.07.
| Revenue | 30.80M |
| Gross Profit | 15.30M |
| Operating Income | -24.80M |
| Pretax Income | -24.50M |
| Net Income | -21.70M |
| EBITDA | -22.20M |
| EBIT | -24.80M |
| Loss Per Share | -0.07 |
Balance Sheet
The company has 18.50 million in cash and 8.30 million in debt, giving a net cash position of 10.20 million or 0.03 per share.
| Cash & Cash Equivalents | 18.50M |
| Total Debt | 8.30M |
| Net Cash | 10.20M |
| Net Cash Per Share | 0.03 |
| Equity (Book Value) | 59.80M |
| Book Value Per Share | 0.17 |
| Working Capital | 28.00M |
Cash Flow
In the last 12 months, operating cash flow was -21.60 million and capital expenditures -1.20 million, giving a free cash flow of -22.80 million.
| Operating Cash Flow | -21.60M |
| Capital Expenditures | -1.20M |
| Free Cash Flow | -22.80M |
| FCF Per Share | -0.06 |
Margins
Gross margin is 49.68%, with operating and profit margins of -80.52% and -70.45%.
| Gross Margin | 49.68% |
| Operating Margin | -80.52% |
| Pretax Margin | -79.55% |
| Profit Margin | -70.45% |
| EBITDA Margin | -72.08% |
| EBIT Margin | -80.52% |
| FCF Margin | -74.03% |
Dividends & Yields
Creo Medical Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -72.61% |
| Shareholder Yield | -72.61% |
| Earnings Yield | -24.11% |
| FCF Yield | -22.54% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |